Bristol-Myers Squibb
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
CEOChristopher S. Boerner
CEOChristopher S. Boerner
Employees34,100
Employees34,100
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded1933
Founded1933
Employees34,100
Employees34,100
BMY Key Statistics
Market cap95.39B
Market cap95.39B
Price-Earnings ratio17.60
Price-Earnings ratio17.60
Dividend yield5.20%
Dividend yield5.20%
Average volume17.23M
Average volume17.23M
High today$47.12
High today$47.12
Low today$46.70
Low today$46.70
Open price$46.96
Open price$46.96
Volume7.04M
Volume7.04M
52 Week high$63.33
52 Week high$63.33
52 Week low$39.35
52 Week low$39.35
BMY News
Simply Wall St 3d
Bristol-Myers Squibb Appoints Cari Gallman As New General Counselrecently appointed Cari Gallman as the new Executive Vice President, General Counsel, and Chief Policy Officer following Sandra Leung’s retirement. This leaders...
Simply Wall St 4d
We Think Bristol-Myers Squibb's Robust Earnings Are ConservativeBristol-Myers Squibb Company ( ) just reported healthy earnings but the stock price didn't move much. We think that investors have missed some encouraging facto...
Analyst ratings
71%
of 28 ratingsBuy
25%
Hold
71.4%
Sell
3.6%
People also own
Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.